A class action lawsuit has been filed against Inspire Medical Systems Inc. on behalf of investors who suffered losses between August 6, 2024, and August 4, 2025. The complaint alleges that the company made false and misleading statements regarding the launch of its new product, Inspire V. According to the lawsuit, the launch was unsuccessful due to weak demand and surplus inventory among providers, who were hesitant to adopt the new treatment. The company is also accused of failing to complete essential launch preparations, including training and onboarding treatment centers, setting up IT systems, updating insurer claims software, and ensuring Medicare reimbursement. These alleged missteps reportedly contradicted public assurances that the launch was progressing successfully.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inspire Medical Systems Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1115404) on December 08, 2025, and is solely responsible for the information contained therein.
Comments